BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

458 related articles for article (PubMed ID: 11514374)

  • 1. Efficacy of pacing therapies for treating atrial tachyarrhythmias in patients with ventricular arrhythmias receiving a dual-chamber implantable cardioverter defibrillator.
    Adler SW; Wolpert C; Warman EN; Musley SK; Koehler JL; Euler DE
    Circulation; 2001 Aug; 104(8):887-92. PubMed ID: 11514374
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safety and efficacy of advanced atrial pacing therapies for atrial tachyarrhythmias in patients with a new implantable dual chamber cardioverter-defibrillator.
    Gillis AM; Unterberg-Buchwald C; Schmidinger H; Massimo S; Wolfe K; Kavaney DJ; Otterness MF; Hohnloser SH;
    J Am Coll Cardiol; 2002 Nov; 40(9):1653-9. PubMed ID: 12427419
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical experience with a dual-chamber implantable cardioverter defibrillator to treat atrial tachyarrhythmias.
    Gold MR; Sulke N; Schwartzman DS; Mehra R; Euler DE;
    J Cardiovasc Electrophysiol; 2001 Nov; 12(11):1247-53. PubMed ID: 11761411
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effectiveness of rapid atrial pacing for termination of drug refractory atrial fibrillation: results of a dual chamber implantable cardioverter defibrillator trial.
    Gold MR; Leman RB; Euler DE
    Card Electrophysiol Rev; 2003 Dec; 7(4):341-4. PubMed ID: 15071249
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnosis and therapy of atrial tachyarrhythmias in the dual chamber implantable cardioverter defibrillator.
    Dijkman B; Wellens HJ
    J Cardiovasc Electrophysiol; 2000 Nov; 11(11):1196-205. PubMed ID: 11083239
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Worldwide clinical experience with a new dual-chamber implantable cardioverter defibrillator system.
    Schoels W; Swerdlow CD; Jung W; Stein KM; Seidl K; Haffajee CJ;
    J Cardiovasc Electrophysiol; 2001 May; 12(5):521-8. PubMed ID: 11386511
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Atrial pacing therapies for prevention of atrial fibrillation in patients with implantable defibrillators.
    Gillis AM
    Card Electrophysiol Rev; 2003 Dec; 7(4):345-7. PubMed ID: 15071250
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of atrial fibrillation and flutter by a dual-chamber implantable cardioverter-defibrillator. For the Worldwide Jewel AF Investigators.
    Swerdlow CD; Schsls W; Dijkman B; Jung W; Sheth NV; Olson WH; Gunderson BD
    Circulation; 2000 Feb; 101(8):878-85. PubMed ID: 10694527
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduction of ventricular tachyarrhythmia by treatment of atrial fibrillation in ICD patients with dual-chamber implantable cardioverter/defibrillators capable of atrial therapy delivery: the REVERT-AF Study.
    Gradaus R; Seidl K; Korte T; Himmrich E; Wieneke H; Schuchert A; Bauer W; Gerss J; Wollmann CG; Borggrefe M; Böcker D
    Europace; 2007 Jul; 9(7):534-9. PubMed ID: 17440005
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of a dual chamber implantable cardioverter defibrillator for the treatment of atrial and ventricular arrhythmias.
    Boriani G; Wollmann C; Biffi M; Kühl M; Schuchert A; Sperzel J; Stiller S; Gasparini G; Böcker D
    Pacing Clin Electrophysiol; 2003 Jan; 26(1P2):461-5. PubMed ID: 12687868
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical experience with implantable atrial and combined atrioventricular defibrillators.
    Jung W; Wolpert C; Esmailzadeh B; Spehl S; Herwig S; Schumacher B; Lewalter T; Omran H; Schimpf R; Vahlhaus C; Welz A; Lüderitz B
    J Interv Card Electrophysiol; 2000 Jan; 4 Suppl 1():185-95. PubMed ID: 10590507
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Merits and limitations of the mode switching rate stabilization pacing algorithms in the implantable cardioverter defibrillator.
    Dijkman B; Wellens HJ
    J Interv Card Electrophysiol; 2001 Sep; 5(3):309-18. PubMed ID: 11500586
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of atrial antitachycardia pacing treatments in patients with an atrial defibrillator: randomised study comparing subthreshold and nominal pacing outputs.
    Mitchell AR; Spurrell PA; Cheatle L; Sulke N
    Heart; 2002 May; 87(5):433-7. PubMed ID: 11997413
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association between ventricular pacing and persistent atrial fibrillation in patients indicated to elective pacemaker replacement: Results of the Prefer for Elective Replacement MVP (PreFER MVP) randomized study.
    Ricci RP; Botto GL; Bénézet JM; Nielsen JC; De Roy L; Piot O; Quesada A; Quaglione R; Vaccari D; Mangoni L; Grammatico A; Kozák M;
    Heart Rhythm; 2015 Nov; 12(11):2239-46. PubMed ID: 26142300
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Atrial fibrillation reduces the atrial impedance amplitude during cardiac cycle: a novel detection algorithm to improve recognition of atrial fibrillation in pacemaker patients.
    Schmidt B; Asbach S; Schweika O; Zehender M; Bode C; Faber TS
    Europace; 2007 Sep; 9(9):812-6. PubMed ID: 17545214
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Catheter ablation of inducible atrial flutter, in combination with atrial pacing and antiarrhythmic drugs ("hybrid therapy") improves rhythm control in patients with refractory atrial fibrillation.
    Prakash A; Saksena S; Krol RB; Filipecki A; Philip G
    J Interv Card Electrophysiol; 2002 Jun; 6(2):165-72. PubMed ID: 11992027
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Randomized comparison between Ramp and Burst+ atrial antitachycardia pacing therapies in patients suffering from sinus node disease and atrial fibrillation and implanted with a DDDRP device.
    Gulizia M; Mangiameli S; Orazi S; Chiarandà G; Boriani G; Piccione G; DiGiovanni N; Colletti A; Puntrello C; Butera G; Vasco C; Vaccaro I; Scardace G; Grammatico A;
    Europace; 2006 Jul; 8(7):465-73. PubMed ID: 16798758
    [TBL] [Abstract][Full Text] [Related]  

  • 18. First worldwide clinical experience with a new dual chamber implantable cardioverter defibrillator. Advantages and complications. The Ventak AV II DR investigators.
    Sticherling C; Schaumann A; Klingenheben T; Hohnloser SH
    Europace; 1999 Apr; 1(2):96-102. PubMed ID: 11233190
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical experience with tiered atrial therapies and atrial arrhythmia prevention algorithms in a dual chamber cardioverter defibrillator.
    Daoud EG; Nademanee K; Fuenzalida C; Tomassoni GF; Schuger C; Chisner M; Simones M; Schwartz M; Reeve H
    J Cardiovasc Electrophysiol; 2006 Aug; 17(8):852-6. PubMed ID: 16903964
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of induced and spontaneous atrial tachyarrhythmias in patients with a history of spontaneous atrial tachyarrhythmias.
    Wollmann CG; Birnie D; Tang A; Boriani G; Kühl M; Böcker D;
    J Cardiovasc Electrophysiol; 2005 Aug; 16(8):818-22. PubMed ID: 16101621
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.